pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 3
    GLM-101
    Congenital Disorder of Glycosylation Type I A Glycomine Inc
  • Preclinical
    GLR-2007
    Malignant Glioma Gan & Lee Pharmaceuticals Co Ltd
  • Phase 2
    GLY-200
    Type 2 Diabetes Glyscend Inc
  • GLYBURIDE AND METFORMIN HYDROCHLORIDE
← prev
page 100 of 271
next →
Pain89
Neurology1
GLYBURIDE AND METFORMIN HYDROCHLORIDE
no indication
AUROBINDO PHARMA
  • GLYXAMBI
    GLYXAMBI (EMPAGLIFLOZIN)
    no indication Boehringer Ingelheim Corp
  • Preclinical
    GM-0111
    Oral Mucositis GlycoMira Therapeutics Inc
  • Phase 1
    GM-60106
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… JD Bioscience Inc
  • Phase 1
    GMA-301
    Pulmonary Arterial Hypertension Gmax Biopharm LLC
  • Phase 1
    GNS-3545
    Idiopathic Pulmonary Fibrosis Genosco Inc
  • Phase 1
    GNSC-001
    Osteoarthritis Genascence Corp
  • Phase 2
    GNT-0003
    Crigler-Najjar Syndrome Genethon SA
  • Preclinical
    GNT-0008
    Limb-Girdle Muscular Dystrophy Atamyo Therapeutics SAS
  • Phase 1
    GNTI-122
    Type 1 Diabetes (Juvenile Diabetes) GentiBio Inc
  • Preclinical
    GNTbm-TKI
    Neuroendocrine Tumors Great Novel Therapeutics Biotech & Medicals Corp
  • Phase 2
    GO-2032c
    Refractory Acute Myeloid Leukemia Genus Oncology LLC
  • GOLYTELY
    GOLYTELY (POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE)
    no indication AZURITY
  • GOZELLIX
    GOZELLIX (GOZETOTIDE)
    no indication TELIX INNOVATIONS
  • Preclinical
    GP-119
    Alzheimer's Disease GliaPharm SA
  • Phase 3
    GP-2
    Human Epidermal Growth Factor Receptor 2 Positive Breast…$GLSI Greenwich LifeSciences, Inc.
  • Phase 2
    GP-531
    Congestive Heart Failure (Heart Failure) ViCardia Therapeutics Inc
  • Preclinical
    GPX-002
    Type 1 Diabetes (Juvenile Diabetes)$GNPX Genprex, Inc.
  • Phase 1
    GRC-39815
    Chronic Obstructive Pulmonary Disease (COPD) Glenmark Pharmaceuticals Ltd
  • Phase 2
    GRC-54276
    Bile Duct Cancer (Cholangiocarcinoma) Ichnos Glenmark Innovation
  • Phase 2
    GRF-312
    Keratoconjunctivitis Sicca (Dry Eye)$GRFS Grifols SA
  • Preclinical
    GRI-0803
    Systemic Lupus Erythematosus$GRI GRI Bio, Inc.
  • Phase 1
    GRN-300
    Triple-Negative Breast Cancer (TNBC) Greenfire Bio LLC
  • Phase 2
    GS-030
    Retinitis Pigmentosa (Retinitis) GenSight Biologics SA
  • Phase 1
    GS-0321
    Solid Tumor$GILD GILEAD SCIENCES, INC.
  • Phase 3
    GS-100
    no indication Grace Science LLC
  • Phase 1
    GS-6791
    Rheumatoid Arthritis$GILD GILEAD SCIENCES, INC.